XIA Guang-rong,LIU Gui-mei,HE Wen,JIN Guo-hua,XIE Ru-ming,XU Yong-xiang,LI Xiao-bo,LI Xue-bing.Application of CT perfusion imaging in radiotherapy for lung cancer[J].Chinese Journal of Radiological Medicine and Protection,2011,31(5):579-582
Application of CT perfusion imaging in radiotherapy for lung cancer
Received:March 23, 2011  
DOI:10.3760/cma.j.issn.0254-5098.2011.05.019
KeyWords:Computed tomography  Perfusion imaging  Lung cancer  Radiotherapy
FundProject:
Author NameAffiliation
XIA Guang-rong Department of Radiation Oncology, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China 
LIU Gui-mei 101149 北京,首都医科大学附属北京胸科医院放疗科 
HE Wen 首都医科大学附属北京友谊医院影像科 
JIN Guo-hua 101149 北京,首都医科大学附属北京胸科医院放疗科 
XIE Ru-ming 101149 北京,首都医科大学附属北京胸科医院放射科 
XU Yong-xiang 101149 北京,首都医科大学附属北京胸科医院放疗科 
LI Xiao-bo 101149 北京,首都医科大学附属北京胸科医院放疗科 
LI Xue-bing 101149 北京,首都医科大学附属北京胸科医院综合科 
Hits: 3858
Download times: 1918
Abstract::
      Objective To investigate the value of CT perfusion imaging in evaluation of therapeutic effect and prognosis in radiotherapy for lung cancer. Methods Fifty-one cases of lung cancer who were unable or refused to be operated on, 36 males and 15 females, aged 37-80, underwent CT perfusion imaging,29 of which only before radiotherapy and 22 before and after radiotherapy twice. The images were collected by cine dynamic scanning (5 mm/4 slices) and input into the GE AW4.0 workstation for data processing. The slice positions of CT imaging were determined according to the largest tumor size in CT scan. Regions of interest of tumor were drawn at the region corresponding to the original images of CT perfusion. Radiotherapy was performed after CT perfusion imaging. Relevant parameters, including blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability surface (PS) were calculated. The treatment response after radiotherapy was evaluated by RECIST. At 2-4 weeks after the treatment, CT examination was conducted once more. Results The tests of the 51 patients showed that the BV was 13.6 ml ·100 g-1, the BF was 129.5 ml ·min-1 ·100 g-1,the MTT was 9.1 s, and the PS was 10.0 ml ·min-1 ·100 g-1 before radiotherapy. The tests of the 22 of the 51 patients showed that the values of BV and BF after radiotherapy were 7.6 ml ·100 g-1 and 97.8 ml ·min-1 ·100 g-1, respectively, both lower than those before radiotherapy (11.2 and 108.7 ml ·min-1 ·100 g-1, respectively), however, both not significantly (t=1.28, 0.40, P>0.05); and the values of MTT and PS after radiotherapy were 8.9 s and 7.8 ml ·min-1 ·100 g-1, respectively, both not significantly higher than those before radiotherapy (7.2 s and 6.8 ml ·min-1 ·100 g-1, respectively, t=-1.15, -0.57, P>0.05). The mean area of tumor after radiotherapy was 1189.6 mm2, significantly less than that before radiotherapy (1920.3 mm2, t=3.98, P<0.05). The MTT of the SCLC patients was 12.9 s, significantly longer than that of the NSCLC patients (6.5 s, t=2.54, P<0.05). The MTT of the tumor with the area≤10 cm2 was 11.2 s, significantly longer than that of the tumors with an area >10 cm2 (5.8 s,t=2.59, P<0.05). The BV of the responder group was 19.2 ml ·100 g-1, significantly higher than that of the non-responder group (4.6 ml ·100 g-1, t=3.62, P<0.05). There were not significant differences in all the perfusion characteristics between the cases with the disease-free advanced survival time ≤10 months and those with disease-free advanced survival time >10 months. Conclusions CT perfusion imaging helps in diagnosis and radiotherapy of lung cancer to a certain degree.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9061799  On-line:0

v
Scan QR Code
&et=DCA5CABA83612A949830E4D5A38BF085C3660E2D0C887670D7DFB01861BDA2EAABB806C5B62178182E43CA4A1ACE05CB760589D385D9750C2FC46540F740FAF3181698C61904D11D&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9377ED8094509821&aid=3897C9445ED3113A410EEECE1FDE14FE&vid=&iid=94C357A881DFC066&sid=57EA20F731155703&eid=90773C2285A2F0BB&fileno=20110519&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9377ED8094509821"; var my_aid="3897C9445ED3113A410EEECE1FDE14FE";